Joshua Phillips, MD
Allergy & Immunology · Jackson, MSNPI 1407955537
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $16,237 of the $20,356 with a category attached, or 79.8%. It is spread thinly across 38 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations.
Across 813 payments — averaging $25.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optinose US, Inc.$4K
- AstraZeneca$3K
- CSL Behring$2K
- Regeneron Healthcare Solutions, Inc.$2K
- GSK$2K
- Genentech USA, Inc.$1K
- plus $6K from 32 others
What the payments were for
- Consulting fees$2,50012%
- Speaking & faculty fees$5253%
- Travel & lodging$8884%
- Food & beverage$16,23780%
- Education$2071%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optinose US, Inc. | 17 | $3,678 |
| AstraZeneca | 113 | $2,845 |
| CSL Behring | 87 | $2,378 |
| Regeneron Healthcare Solutions, Inc. | 92 | $2,108 |
| GSK | 129 | $1,685 |
| Genentech USA, Inc. | 61 | $1,291 |
| Novartis | 63 | $1,154 |
| Aimmune Therapeutics, Inc. | 6 | $690 |
| Pfizer | 38 | $668 |
| Amgen | 33 | $550 |
| Takeda Pharmaceuticals U.S.A., Inc. | 27 | $501 |
| Grifols USA, LLC | 24 | $438 |
| Octapharma USA, Inc. | 11 | $246 |
| Boehringer Ingelheim | 15 | $217 |
| Galderma Laboratories, L.p. | 8 | $189 |
| Pharming Healthcare, Inc. | 10 | $183 |
| Kaleo, Inc. | 12 | $171 |
| Sanofi | 7 | $169 |
| Ionis Pharmaceuticals, Inc. | 4 | $139 |
| LEO Pharma Inc. | 7 | $134 |
| AbbVie | 6 | $99 |
| QOL Medical, LLC | 5 | $97 |
| Merck | 5 | $97 |
| Blueprint Medicines Corporation | 3 | $91 |
| Shire North American Group Inc | 5 | $89 |
| Teva Pharmaceuticals USA, Inc. | 7 | $87 |
| Johnson & Johnson | 1 | $77 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $40 |
| Insmed, Inc. | 2 | $39 |
| Biocryst US Sales Co., LLC | 2 | $39 |
| Organon | 2 | $29 |
| Lilly USA, LLC | 2 | $29 |
| PARI Respiratory Equipment, Inc. | 1 | $27 |
| Biocryst Pharmaceuticals, Inc. | 2 | $25 |
| Greer Laboratories, Inc. | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
| Incyte Corporation | 1 | $13 |
| Almirall LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$20,356 in reported general payments places this provider in the 70th percentile of 28 allergy & immunology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 113 | $74,701 |
| Spiriva RespimatTiotropium Bromide | 28 | $21,025 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 27 | $17,038 |
| Breo ElliptaFluticasone/Vilanterol | 42 | $16,143 |
| Advair HfaFluticasone Propion/Salmeterol | 34 | $14,536 |
| SymbicortBudesonide/Formoterol Fumarate | 33 | $9,165 |
| Epinephrine | 31 | $6,800 |
| Incruse ElliptaUmeclidinium Bromide | 17 | $5,879 |
| BreynaBudesonide/Formoterol Fumarate | 22 | $5,531 |
| Fluticasone Propionate | 266 | $3,982 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 31 | $3,758 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 118 | $3,366 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 24 | $3,244 |
| Montelukast Sodium | 465 | $2,691 |
| Azelastine Hcl | 44 | $2,369 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta | $1,685 | $96,722172 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $2,845 | $26,20360 claims |
| Boehringer IngelheimSpiriva Respimat | $217 | $21,02528 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 28 allergy & immunology providers in Mississippi.
Other allergy & immunology in Jackson
- Todd AdkinsJackson$226K
- Daniel VenarskeJackson$156K
- Dexter WalcottJackson$154K
- Chelle WilhelmJackson$61K
- Claire RosenblattJackson$11K
- James HaltomJackson$11K
- Gailen MarshallJackson$4K
- Sheryll VincentJackson$3K
- Matthew ElliottJackson$862
- Stephen KempJackson$68
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.